A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2006
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863779A Novel indazole derivative
11/15/2006	CN1863522A Ophthalmic composition for treating lacrimal disorders
11/15/2006	CN1861154A Tablets for treating deaf and its prepn. method
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861063A Ophthalmic gel contg. neo-decanoy acetaldehyde sodium
11/15/2006	CN1284793C C-aryl glucoside sglt2 inhibitors
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	CA2362233C Process for cross-linking hyaluronic acid to polymers
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/09/2006	WO2006119258A2 Use of hydrogen sulfide in the treatment of eye diseases
11/09/2006	WO2006119211A2 Methods and compositions for treating ocular disorders
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118299A1 Gpcr inhibitor
11/09/2006	WO2006118170A1 Therapeutic agent for corneal disease
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006097337A9 11β-HYDROXYSTEROID DEHYDROGENASES
11/09/2006	US20060252943 Chemical process
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252780 Fused pyrimidine derivatives
11/09/2006	US20060252765 Corneal perception recovery drug containing amide compound
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251621 Ocular gene therapy
11/09/2006	CA2607506A1 Novel lactam compound
11/09/2006	CA2606989A1 Vascular targeting of ocular neovascularization
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719774A2 Preventive or therapeutic agent for diabetic maculopathy
11/08/2006	EP1719521A1 Preventive and/or remedy for retinopathy
11/08/2006	EP1719517A1 Artificial physiological salt solution and process for producing the same
11/08/2006	EP1719506A1 Gene expression controlling agent
11/08/2006	EP1718314A1 Heparin for the treatment of ocular pathologies
11/08/2006	EP1718302A1 Organic compounds
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	EP1429761B1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
11/08/2006	EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	CN1859903A Use of EP2 selective receptor agonists in medical treatment
11/08/2006	CN1857675A Zedoary oil eye drop and its preparing method
11/08/2006	CN1857626A Chinese medicine preparation for treating diabetic eye complication
11/08/2006	CN1857620A Quality control method for visual fatigue treating medicine preparation
11/08/2006	CN1857604A Sheep liver preparation for improving visual acuity and its preparing process
11/08/2006	CN1857574A Deafness treating Tongqiao Preparation and its preparing process
11/08/2006	CN1857531A Recipe, preparing process and application of Chinese medicine preparation for treating diabetic retinopathy
11/08/2006	CN1857506A Instant cordate houttuynia gel preparation for eye and its preparing method
11/08/2006	CN1857456A Eye medicine for treating senile cataract and its pH value regulating method and preparing process
11/08/2006	CN1857420A Chinese medicine preparation for treating eye fatigue and myopia and its preparing process
11/08/2006	CN1857324A Biologically synthesized eye drop for treating presbyopia and visual fatigue syndrome
11/08/2006	CN1857301A Composition for matching with contact lenses and its application
11/08/2006	CN1857199A Eye drop containing tranilast and its preparing process
11/08/2006	CN1283639C Pirenzepine organic acid salt and eye drops for treating myopia
11/08/2006	CN1283622C Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
11/08/2006	CN1283254C Use of 23-hydroxy betulic acid in preparing administrative and/or preventive drugs for inhibiting blood vessel formation
11/08/2006	CN1283240C Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132409 2-(6-cyano-1-hexyn-1-yl)adenosine; 2(6-cyano-1-hexyn-1yl)adenosine 5' phosphate or salts; for lowering ocular tension, promoting blood flow in retina, protecting optic nerve failure; for treament of glaucoma and ocular hypertension
11/07/2006	US7132259 nucleic acids encoding neurotoxin polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; for biosynthesis of botulinum neurotoxins in host cells
11/07/2006	CA2261988C Mannose-6-phosphate composition and its use in treating fibrotic disorders
11/02/2006	WO2006116591A2 Ophthalmic formulations comprising prednisolone acetate and tobramycin and uses thereof
11/02/2006	WO2006115247A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
11/02/2006	WO2006115245A1 4-ethynylisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115244A1 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115193A1 Remedy for xanthoma
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115185A1 Therapeutic agent for corneal/conjunctival disorder
11/02/2006	WO2006113993A1 MATRIX METALLOPROTEINASE INHIBITORS OF TGFß -INDUCED SUBCAPSULAR CATARACT FORMATION
11/02/2006	WO2006031467A3 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247293 suppressing death of optic nerve cells during ocular hypertension in patient with glaucoma via administering 3-methyl-1-phenyl-2-pyrazolin-5-one; drops, sustained release formulations
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247215 (Z)-7-{(1R,2R)-2-[(E)-5-(3-Chloro-benzo[b]thiophen-2-yl)-3-hydroxy-pent-1-enyl]-6-oxo-cyclohexyl}-hept-5-enoic acid; ocular hypotensives; glaucoma
11/02/2006	US20060247214 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060243276 Methods for treating rhinitis and conjunctivitis
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension

1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 531